Edward S Kapustka, MD in Fort Atkinson, WI - Urology

Edward S Kapustka, MD is a Urology physician based in Fort Atkinson, Wisconsin. Edward S Kapustka is licensed to practice in Wisconsin (license number 18609-020) and his current practice location is 426 Mcmillen St, Fort Atkinson, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (920) 563-7744.

NPI number for Edward S Kapustka is 1447271572 and his current mailing address is 426 Mcmillen St, Fort Atkinson, Wisconsin. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1447271572.

Contact Information

	Edward S Kapustka, MD
	426 Mcmillen St, Fort Atkinson, WI 53538-1996
	(920) 563-7744
	(920) 563-7741

Physician's Profile

Full Name	Edward S Kapustka
Gender	Male
Speciality	Urology
Location	426 Mcmillen St, Fort Atkinson, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1447271572
Provider Enumeration Date: 07/22/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Edward S Kapustka such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447271572	NPI	-	NPPES
31010400	Medicaid	WI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	18609-020 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Edward S Kapustka is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Edward S Kapustka, MD 426 Mcmillen St, Fort Atkinson, WI 53538-1996 Ph: (920) 563-7744	Edward S Kapustka, MD 426 Mcmillen St, Fort Atkinson, WI 53538-1996 Ph: (920) 563-7744

News Archive

Iron nanoparticles exhibit toxic effects on neuronal cells

Researchers at UC San Diego have discovered that iron-containing nanoparticles being tested for use in several biomedical applications can be toxic to nerve cells and interfere with the formation of their signal-transmitting extensions.

LigoCyte to enroll 98 subjects in first clinical trial for bivalent IM norovirus vaccine

LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company focused on the development of innovative vaccine products, announced today that it has initiated the first clinical trial for its bivalent intramuscular (IM) norovirus vaccine candidate, marking the fourth human clinical trial in the Company's norovirus virus-like particle (VLP) vaccine program.

'Survival protein' protects brain against effects of stroke

Johns Hopkins scientists say that a newly discovered "survival protein" protects the brain against the effects of stroke in rodent brain tissue by interfering with a particular kind of cell death that's also implicated in complications from diabetes and heart attack.

PPFA's involvement in infant body parts trafficking must be thoroughly investigated, says AUL

Americans United for Life President and CEO Dr. Charmaine Yoest today sent a letter and detailed legal response to multiple committees and top legal authorities in Congress, now currently investigating the Planned Parenthood Federation of America (PPFA), following release of videos indicating PPFA's involvement in lucrative infant body parts trafficking.

Edward S Kapustka, MD - Urology in Fort Atkinson, WI